• head_banner_01

Nā huahana

  • CJC-1295

    CJC-1295

    Hana ʻia ʻo CJC-1295 API me ka hoʻohana ʻana i ka ʻenehana solid phase peptide synthesis (SPPS) a hoʻomaʻemaʻe ʻia me ka hoʻohana ʻana i ka HPLC e hoʻokō i ka maʻemaʻe kiʻekiʻe a me ka hui pū ʻana.
    Nā hiʻohiʻona huahana:

    Maʻemaʻe ≥ 99%

    ʻO nā mea hoʻoheheʻe koena haʻahaʻa a me nā metala kaumaha

    Endotoxin-noa, non-immunogenic synthesis ala

    Nā nui hiki ke hoʻopilikino ʻia: mg i kg

  • NAD+

    NAD+

    Nā hiʻohiʻona API:

    Maʻemaʻe kiʻekiʻe ≥99%

    NAD+ papa lāʻau lapaʻau

    Nā kūlana hana like GMP

    Kūpono ʻo NAD + API no ka hoʻohana ʻana i nā nutraceuticals, injectables, a me nā mea lapaʻau metabolic holomua.

  • Boc-Tyr(tBu)-Aib-Glu(OtBu)-Gly-OH

    Boc-Tyr(tBu)-Aib-Glu(OtBu)-Gly-OH

    Boc-Tyr(tBu)-Aib-Glu(OtBu)-Gly-OHhe tetrapeptide i pale ʻia i hoʻohana mau ʻia i ka noiʻi synthesis peptide. ʻO nā pūʻulu Boc (tert-butyloxycarbonyl) a me tBu (tert-butyl) he mau pūʻulu pale no ka pale ʻana i nā ʻaoʻao i ka wā o ka hui kaulahao peptide. ʻO ka hoʻokomoʻana o Aib (α-aminoisobutyric acid) e kōkua i ka hoʻouluʻana i nā hanana helical a hoʻonui i ka paʻa o ka peptide. Hoʻopaʻa ʻia kēia kaʻina peptide no kona hiki ke nānā i ka conformational analysis, peptide folding, a ma ke ʻano he hale kūkulu i ka hoʻomohala ʻana i nā peptides bioactive me ka hoʻonui ʻia a me ka kikoʻī.

  • ʻO Cagrilintide

    ʻO Cagrilintide

    ʻO Cagrilintide kahi mea hana agonist amylin receptor agonist lōʻihi i hoʻomohala ʻia no ka mālama ʻana i ka momona a me nā maʻi metabolic pili i ke kaumaha. Ma ka hoʻohālikelike ʻana i ka amylin hormone maoli, kōkua ia i ka hoʻoponopono ʻana i ka ʻai, hoʻolohi i ka hoʻohemo ʻana o ka ʻōpū, a hoʻonui i ka māʻona. Hoʻokumu ʻia kā mākou Cagrilintide API maʻemaʻe kiʻekiʻe ma o ka synthesis kemika a hoʻokō i nā kūlana lāʻau lapaʻau, kūpono ia no ka hoʻohana ʻana i nā hoʻolālā hoʻokele paona kiʻekiʻe.

  • Tesamorelin

    Tesamorelin

    Hoʻohana ʻo Tesamorelin API i ka ʻenehana holomua solid phase peptide synthesis (SPPS) a loaʻa iā ia nā hiʻohiʻona aʻe:

    Maʻemaʻe ≥99% (HPLC)
    ʻAʻohe endotoxin, nā metala kaumaha, nā mea hoʻoheheʻe koena i hoʻāʻo ʻia
    ʻO ke kaʻina amino acid a me ke ʻano i hōʻoia ʻia e LC-MS/NMR
    Hāʻawi i ka hana maʻamau i nā grama i nā kilokani

  • Fmoc-Ile-Aib-OH

    Fmoc-Ile-Aib-OH

    ʻO Fmoc-Ile-Aib-OH kahi poloka hale dipeptide i hoʻohana ʻia i ka solid-phase peptide synthesis (SPPS). Hoʻohui ia i ka isoleucine pale ʻia Fmoc me Aib (α-aminoisobutyric acid), kahi amino acid non-natural e hoʻonui ai i ka paʻa helix a me ka pale protease.

  • Fmoc-L-Lys[Eic(OtBu)-γ-Glu(OtBu)-AEEA-AEEA]-OH

    Fmoc-L-Lys[Eic(OtBu)-γ-Glu(OtBu)-AEEA-AEEA]-OH

    ʻO Fmoc-L-Lys[Eic(OtBu)-γ-Glu(OtBu)-AEEA-AEEA]-OH he mea hoʻohana ʻia ka amino acid building block i hoʻolālā ʻia no ka hāʻawi ʻana i ka lāʻau lapaʻau a me ka bioconjugation. Hōʻike ia i kahi moiety Eic (eicosanoid) no ka pilina lipid, γ-Glu no ka huli ʻana, a me nā spacers AEEA no ka maʻalahi.

  • Boc-Tyr(tBu)-Aib-OH

    Boc-Tyr(tBu)-Aib-OH

    ʻO Boc-Tyr(tBu)-Aib-OH kahi poloka dipeptide pale i hoʻohana ʻia i ka peptide synthesis, e hui pū ana i ka tyrosine pale ʻia ʻo Boc a me Aib (α-aminoisobutyric acid). Hoʻonui ke koena Aib i ka hoʻokumu ʻana i ka helix a me ke kū'ē protease.

  • Boc-His(Trt)-Ala-Glu(OtBu)-Gly-OH

    Boc-His(Trt)-Ala-Glu(OtBu)-Gly-OH

    ʻO Boc-His(Trt)-Ala-Glu(OtBu)-Gly-OH kahi ʻāpana tetrapeptide i pale ʻia i hoʻohana ʻia i ka solid-phase peptide synthesis (SPPS) a me ka hoʻomohala lāʻau peptide. Loaʻa iā ia nā pūʻulu pale no ka synthesis orthogonal a loaʻa i kahi kaʻina e pono ai i ka hoʻolālā peptide bioactive a me ka structural.

  • Fmoc-Lys(Pal-Glu-OtBu)-OH

    Fmoc-Lys(Pal-Glu-OtBu)-OH

    ʻO Fmoc-Lys (Pal-Glu-OtBu) -OH kahi papa hale kūkulu hale lipidated amino acid i hoʻolālā ʻia no ka conjugation peptide-lipid. Hōʻike ia i ka lysine pale ʻia ʻo Fmoc me kahi kaulahao ʻaoʻao palmitoyl-glutamate, hoʻonui i ka pili o ka membrane a me ka bioavailability.

  • Fmoc-His-Aib-OH

    Fmoc-His-Aib-OH

    ʻO Fmoc-His-Aib-OH kahi papa hale dipeptide i hoʻohana ʻia i ka synthesis peptide, e hui pū ana i ka histidine pale ʻia Fmoc a me Aib (α-aminoisobutyric acid). Hoʻokomo ʻo Aib i ka conformational rigidity, i mea waiwai no ka hoʻolālā ʻana i nā peptides helical a paʻa.

  • Boc-His(Trt)-Aib-Glu(OtBu)-Gly-OH

    Boc-His(Trt)-Aib-Glu(OtBu)-Gly-OH

    ʻO Boc-His(Trt)-Aib-Glu(OtBu)-Gly-OH kahi ʻāpana tetrapeptide pale ʻia i hoʻohana ʻia i ka peptide synthesis a me ka hoʻomohala ʻana i ka lāʻau. Loaʻa iā ia nā pūʻulu hana i pale ʻia no ka hoʻopili stepwise a me nā hiʻohiʻona Aib (α-aminoisobutyric acid) e hoʻonui ai i ka paʻa helix a me ka rigidity conformational.

<< < Mamua123456Aʻe >>> ʻAoʻao 3 / 11